Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve To consider and approve inter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has informed BSE that its Board of Directors will meet on Monday, 26 May 2025, to consider and approve the audited financial results for the quarter and full financial year ended March 31, 2025. The filing is made under SEBI Listing Regulations (Reg. 29(1)). The trading window for dealing in the company's securities will remain closed until end of business on 28 May 2025 and reopen on 29 May 2025. No actual financial figures have been disclosed in this intimation — these are expected to come after the board meeting.
This is a routine regulatory intimation ahead of results. Investors should wait for the actual audited Q4/FY25 numbers on or after 26 May 2025 to assess any real impact on the stock. No immediate price-moving information is contained in this filing.